What Is Hypocitraturic Nephrolithiasis?

Hypocitraturic nephrolithiasis is the formation of kidney stones driven, at least in part, by abnormally low levels of citrate in the urine. Citrate is one of the body’s built-in defenses against stone formation: it binds to calcium in the urine and keeps calcium crystals from clumping together into stones. When citrate drops below a threshold, that protective brake weakens, and the risk of calcium-based stones climbs. Low urinary citrate, called hypocitraturia, shows up in roughly 20 to 60 percent of people who form kidney stones, making it one of the most common metabolic abnormalities in the stone-forming population.¹

How Citrate Protects Against Kidney Stones

Citrate does two things in your urine that matter for stone prevention. First, it acts as a calcium chelator: citrate molecules latch onto free calcium ions and form soluble complexes that stay dissolved rather than precipitating out as crystals. Second, even beyond simply soaking up calcium, citrate directly interferes with the nucleation, growth, and aggregation of calcium crystals. In other words, citrate doesn’t just reduce the available calcium; it also makes the remaining calcium crystals less likely to stick together into a stone.²

Oral citrate therapy works on this same principle. When you take a citrate salt by mouth, your urinary citrate rises, more calcium gets bound, and crystallization slows down.³ That straightforward logic is why citrate supplementation has been a mainstay of kidney stone prevention for decades.

What Drives Citrate Levels Up or Down

The kidneys are the gatekeepers of urinary citrate. Citrate is freely filtered at the glomerulus, and a large portion of it gets reabsorbed in the proximal tubule through a dedicated transporter called NaDC1, which sits on the inner surface of the tubule lining throughout its full length.⁴ The more citrate gets pulled back into tubular cells, the less ends up in the final urine. That reabsorption rate is not fixed; it shifts with the body’s acid-base balance.

When your blood is more acidic, kidney cells ramp up citrate reabsorption and consumption. Citrate that enters the cell gets shuttled into mitochondria and burned for energy as part of normal metabolism. In acidosis, the mitochondrial machinery runs faster on citrate, which depletes it from the urine. In alkalosis, the opposite happens: citrate entry into mitochondria slows, cellular citrate builds up, less is reabsorbed from the urine, and urinary citrate rises.⁵ This is why anything that makes your body more acidic tends to push urinary citrate down, and anything that alkalinizes the body tends to push it up.

Common Causes of Hypocitraturia

Hypocitraturia often has no single dramatic cause. In many stone formers, it is labeled idiopathic, meaning it exists without a clear underlying disease. But several well-recognized conditions and habits drive citrate down.¹

Distal Renal Tubular Acidosis

Distal renal tubular acidosis (dRTA) is a condition where the kidney cannot properly acidify the urine. The resulting chronic metabolic acidosis increases citrate reabsorption in the proximal tubule, causing urinary citrate to plummet. People with dRTA are predisposed to forming calcium phosphate kidney stones, and the combination of alkaline urine (from the acidification defect) and very low citrate creates an especially stone-friendly environment.⁶

Gastrointestinal Conditions

Chronic diarrhea, inflammatory bowel disease, and intestinal malabsorption syndromes are major culprits. The gut loses bicarbonate (a base) in loose stool, which tips the body toward acidosis and triggers the kidneys to hold onto citrate. In patients with gastrointestinal malabsorption, daily citrate excretion has been measured at only about 15 percent of normal levels, a dramatic drop driven by both a lower filtered load of citrate arriving at the kidney and abnormally aggressive reabsorption.⁷

Chronic diarrhea also complicates treatment in a practical way. One case report described a patient whose urinary citrate stayed low despite taking potassium citrate tablets, only normalizing after she switched to an equivalent dose in liquid form. The chronic diarrhea apparently impaired absorption of the slow-release tablet, but not the liquid preparation.⁸

Medications

Certain drugs lower urinary citrate as a side effect. Topiramate, an antiseizure medication also prescribed for migraine prevention, is a well-known offender. It inhibits carbonic anhydrase in the kidneys, which causes a mild metabolic acidosis, which in turn drives citrate down and raises stone risk.⁹ Other carbonic anhydrase inhibitors, including acetazolamide (sometimes used for glaucoma or altitude sickness), can do the same thing through the same mechanism. If you are on one of these medications and form kidney stones, the drug itself may be a contributing factor worth discussing with your prescriber.

Diet

What you eat and drink has a surprisingly large influence on citrate excretion. Two dietary patterns stand out: excessive animal protein and excessive sodium. In healthy men, a high-protein diet caused urinary citrate to drop by roughly a third, and adding a high sodium intake on top of the high protein made the changes even more pronounced.¹⁰ Animal protein generates an acid load when metabolized, which circles back to the acid-base mechanism that suppresses citrate. Sodium excess increases urinary calcium loss and independently pushes citrate down.¹¹

A diet low in fruits and vegetables compounds the problem, since these foods provide the potassium and alkali that help maintain citrate excretion. The typical Western diet, heavy in meat and processed food and light on produce, is essentially designed to lower urinary citrate.

Low Potassium

Hypokalemia (low serum potassium) promotes intracellular acidosis in kidney tubule cells, which increases citrate reabsorption. This can happen from diuretic use, poor dietary potassium intake, or any condition causing potassium wasting. The potassium connection is also why potassium citrate, rather than sodium citrate, is the preferred supplement for treatment: it addresses both the citrate deficit and a possible potassium deficit at once.

How Hypocitraturia Is Diagnosed

The standard diagnostic test is a 24-hour urine collection. You collect all your urine over a full day, and the lab measures citrate along with other stone-risk factors like calcium, oxalate, uric acid, sodium, and urine pH. Hypocitraturia is often defined as urinary citrate below 320 mg per day, though exact cutoffs vary slightly between laboratories.²

In stone-forming populations, hypocitraturia frequently turns up as the single most common metabolic abnormality. One study of South Asian stone formers found it in 65 percent of patients, with nearly half of all stone formers showing isolated hypocitraturia as their only identifiable metabolic problem.¹² In other words, for many people who keep forming stones, low citrate is the entire explanation from a lab standpoint.

That said, the 24-hour urine collection has its limitations. It captures a snapshot of one day’s chemistry, which can vary with diet, hydration, activity, and timing. Guidelines support its use in high-risk or motivated patients, though the evidence that it precisely predicts recurrence or guides treatment response is still limited.¹³ Despite those limitations, it remains the best widely available tool for identifying hypocitraturia and other correctable metabolic abnormalities.

Potassium Citrate as the Cornerstone Treatment

Potassium citrate is the first-line pharmacologic treatment for hypocitraturic nephrolithiasis. It raises urinary citrate, raises urine pH (making the urine less acidic), and supplies potassium. In patients with distal renal tubular acidosis, the results can be dramatic: in one study, none of nine patients formed new stones during a mean treatment period of about three years on potassium citrate, despite averaging dozens of stones per patient in the three years before treatment.¹⁴

You might wonder why doctors prescribe potassium citrate specifically instead of, say, sodium citrate, since both deliver citrate. The difference matters. Potassium citrate lowers urinary calcium at the same time it raises citrate, which reduces the saturation of calcium oxalate in the urine. Sodium citrate raises citrate just as well, but it does not lower urinary calcium because the extra sodium load increases calcium excretion. In head-to-head comparisons, potassium citrate dropped urinary calcium while sodium citrate left it essentially unchanged.¹⁵ Sodium citrate also raised the saturation of calcium phosphate (brushite) and sodium urate, potentially creating new stone risks while solving the old one.¹⁶ For calcium stone formers, potassium citrate is clearly the better choice.

Adherence Challenges

Potassium citrate works, but taking it consistently is another story. The tablets are large. They need to be taken two or three times a day. They can cause gastrointestinal upset, especially nausea and bloating. Many patients start treatment enthusiastically and then drift away from it over months. Adherence to potassium citrate limits the real-world effectiveness of preventive therapy for kidney stones, and monitoring whether patients actually take their medication remains an ongoing challenge in clinical practice.¹⁷

If you struggle with the tablets, a liquid preparation may be an option, though it has a strongly salty-sour taste that some people find even more unpleasant. Crystal or powder forms dissolved in water are also available. Each formulation has its own tolerability profile, and switching formulations is a reasonable conversation to have with your doctor rather than quietly stopping treatment altogether.

The Lemonade Question

Given the tolerability issues with potassium citrate pills, researchers have investigated whether simply drinking lemonade could boost urinary citrate enough to matter. Lemons are rich in citric acid, and the idea has real appeal: a natural, inexpensive, pleasant-tasting intervention.

The results are genuinely encouraging, though not spectacular. In one early study, 11 of 12 patients with hypocitraturic calcium nephrolithiasis showed increased urinary citrate during lemonade therapy, with average levels rising from about 142 mg per day at baseline to 346 mg per day. Seven of the twelve patients became normocitraturic (reached normal citrate levels) on lemonade alone.¹⁸ A longer-term follow-up in a similar group found a mean citrate increase of 383 mg per day.¹⁹

One nuance: not all lemonades are equal. A study comparing regular lemonade with diet lemonade found that only the diet version significantly increased urinary citrate from baseline, possibly because the sugar in regular lemonade partially offset the citrate benefit through different metabolic pathways.²⁰ Lemonade is not a replacement for potassium citrate in people with severe hypocitraturia or underlying conditions like dRTA, but it can serve as a useful adjunct or as a starting point for patients with mild deficits who want to try dietary changes before committing to medication.

Rising Prevalence Over Time

Hypocitraturia appears to be getting more common among stone formers, not less. A retrospective analysis comparing metabolic profiles across two time periods found that the prevalence of hypocitraturia among stone formers rose from 46 percent in the late 1980s and early 1990s to 60 percent by the late 2000s and early 2010s.² The drivers behind that increase are not fully established, but shifts in dietary habits are a strong candidate. Over those same decades, processed food consumption and sodium intake in many populations trended upward, while fruit and vegetable intake remained stagnant or declined. Both patterns push citrate down.

This trend also aligns with the broader rise in kidney stone prevalence that has been observed in multiple countries over the past few decades. Hypocitraturia is not the whole story behind that increase (obesity, diabetes, and climate-related dehydration all play roles), but a population-wide decline in urinary citrate from dietary changes could be contributing.

Hypocitraturia and Bone Health

People who form kidney stones have higher rates of low bone density and fractures than the general population, and researchers have asked whether hypocitraturia itself might be part of the explanation. The reasoning is plausible: chronic metabolic acidosis (which drives hypocitraturia) also pulls calcium out of bone to buffer the acid load, potentially weakening the skeleton over time.

A large study of kidney stone patients found that those with severe hypocitraturia had a modestly elevated risk of osteoporosis or fracture in unadjusted analysis. However, once demographic factors, other lab abnormalities, and comorbid conditions were accounted for, the association was no longer statistically significant.²¹ The conclusion was that while a modest link may exist, other factors probably explain most of the bone disease seen in stone formers. Still, the finding reinforces the idea that correcting chronic acidosis with alkali therapy like potassium citrate could have benefits beyond stone prevention alone, since the same metabolic imbalance that suppresses citrate can also stress the skeleton.

When to Suspect Hypocitraturia

Hypocitraturia has no symptoms of its own. You will not feel it. It only shows up on a lab test or reveals itself indirectly through recurrent kidney stones. Certain patterns should raise suspicion that low citrate is playing a role:

Recurrent calcium stones: especially if other common risk factors like high urinary calcium or high oxalate are absent or already controlled.
Known dRTA or chronic diarrhea: both conditions predictably lower citrate, and screening is straightforward.
Use of topiramate or other carbonic anhydrase inhibitors: if you started forming stones after beginning one of these medications, drug-induced hypocitraturia is a likely explanation.
High-protein, high-sodium, low-produce diet: dietary patterns that push acid load up and alkali intake down are a common but correctable cause.

For anyone who has had more than one calcium kidney stone, a 24-hour urine collection is a reasonable next step. Hypocitraturia is treatable, and identifying it changes the management plan in concrete ways: it points toward potassium citrate supplementation, dietary modification, or both. It also helps distinguish patients whose stones are driven by a correctable metabolic problem from those who may need a different intervention entirely.

1
PubMed Central. Hypocitraturia: pathophysiology and medical management
2
Clinical Kidney Journal. Citrate and calcium kidney stones
3
PubMed Central. Citrate salts for preventing and treating calcium containing kidney stones in adults
4
PubMed Central. Expression of sodium-dependent dicarboxylate transporter 1 (NaDC1/SLC13A2) in normal and neoplastic human kidney
5
PubMed. Citrate excretion: a window on renal metabolism
6
Kidney Medicine. What Is Hypocitraturic Nephrolithiasis?
7
PubMed. Hypocitraturia in patients with gastrointestinal malabsorption
8
PubMed Central. Hypocitraturia Despite Potassium Citrate Tablet Supplementation
9
PubMed. Topiramate-induced nephrolithiasis
10
PubMed. The effects of dietary excesses in animal protein and in sodium on the composition and the crystallization kinetics of calcium oxalate monohydrate in urines of healthy men
11
PubMed. Citrate and renal calculi: new insights and future directions
12
African Journal of Urology. Hypocitraturia and urolithiasis risk: Insights from a 24-h urinary metabolic evaluation in South-Asian stone formers
13
PubMed. The Role of the 24-Hour Urine Collection in the Prevention of Kidney Stone Recurrence
14
PubMed. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis
15
PubMed. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts
16
PubMed. Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate
17
PubMed. Adherence to Potassium Citrate, Changes in 24-Hour Stone Risk Parameters, and Recurrent Kidney Stone Events
18
PubMed. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis
19
PubMed. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis
20
Journal of Endourology. The effect of lemonade and diet lemonade upon urinary parameters affecting calcium urinary stone formation
21
PubMed Central. Hypocitraturia and Risk of Bone Disease in Patients With Kidney Stone Disease